Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety

European Journal of Medicinal Chemistry
2012.0

Abstract

Series of novel derivatives of quinazoline containing thiosemicarbazide moiety 5 and 9 have been synthesized and tested for their antitumor activities in vitro against a panel of five human cancer cell lines. Bioassay results indicated that most of the prepared compounds exhibited cytotoxicity against various cancer cells. From the structure-activity relationships it was found that unsubstituted quinazoline ring and benzene ring or halogen substituted benzene ring in quinazoline derivatives 5 and 9 would be the most favorable for their antitumor activity.

Knowledge Graph

Similar Paper

Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety
European Journal of Medicinal Chemistry 2012.0
Antitumor and antileishmanial evaluation of novel heterocycles derived from quinazoline scaffold: a molecular modeling approach
Medicinal Chemistry Research 2013.0
Synthesis and screening of 2-(2-(4-substituted piperazine-1-yl)-5-phenylthiazol-4-yl)-3-aryl quinazolinone derivatives as anticancer agents
Medicinal Chemistry Research 2013.0
Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and in vitro antiproliferative activity of 5-alkyl-12(H)-quino[3,4-b] [1,4]benzothiazinium salts
European Journal of Medicinal Chemistry 2010.0
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives
European Journal of Medicinal Chemistry 2010.0
Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Antitumor activity of (−)-α-bisabolol-based thiosemicarbazones against human tumor cell lines
European Journal of Medicinal Chemistry 2010.0